Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rao Fu, Jake Gundrum & Anita H Sung. (2018) Health-care utilization and outcomes of patients at high risk of invasive fungal infection. ClinicoEconomics and Outcomes Research 10, pages 371-387.
Read now
Read now
Articles from other publishers (18)
Hyunkyung Park, Jeonghwan Youk, Dong-Yeop Shin, Junshik Hong, Inho Kim, Nam Joong Kim, Jeong-Ok Lee, Soo-Mee Bang, Sung-Soo Yoon, Wan Beom Park & Youngil Koh. (2019) Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy. BMC Cancer 19:1.
Crossref
Crossref
Lu Xiaoling, Tang Tingyu, Hu Caibao, Zhao Tian & Chen Changqin. (2018) Diagnostic efficacy of serum 1,3-β-D-glucan for invasive fungal infection: An update meta-analysis based on 37 case or cohort studies. Open Medicine 13:1, pages 329-337.
Crossref
Crossref
A. Vena, E. Bouza, A. Álvarez-Uría, J. Gayoso, P. Martín-Rabadán, F. Cajuste, J. Guinea, J. Gómez Castellá, R. Alonso & P. Munoz. (2017) The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin. Clinical Microbiology and Infection 23:12, pages 1000.e1-1000.e4.
Crossref
Crossref
Ryul KimYoungil KohDong-Yeop ShinPyoeng Gyun ChoeNam Joong KimSung-soo YoonMyoung-don OhWan Beom ParkInho Kim. (2017) The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study. Blood Research 52:4, pages 300.
Crossref
Crossref
Song He, Ju-Ping Hang, Ling Zhang, Fang Wang, De-Chun Zhang & Fang-Hong Gong. (2015) A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-d-glucan for invasive fungal infection: Focus on cutoff levels. Journal of Microbiology, Immunology and Infection 48:4, pages 351-361.
Crossref
Crossref
S.M. Heimann, M.J.G.T. Vehreschild, L. Meintker, W. Heinz, T. Schroeder, M. von Bergwelt‐Baildon, O.A. Cornely & J.J. Vehreschild. (2014)
Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato‐oncological high‐risk patients: a web‐based non‐interventional trial in four large university hospitals in
G
ermany
. Transplant Infectious Disease 16:6, pages 968-974.
Crossref
Crossref
D.A. Enoch, S.F. Idris, S.H. Aliyu, C. Micallef, O. Sule & J.A. Karas. (2014) Micafungin for the treatment of invasive aspergillosis. Journal of Infection 68:6, pages 507-526.
Crossref
Crossref
Liping Wan, Chun Wang, Lin Liu, Xiaoqiong Tang, Jinghua Wang, Yue Guan, Ming Jiang, Xianlin Duan, Xiaoyan Ke, Hongmei Jing, Jiong Hu, Ling Wang, Yuming Li & Li Geng. (2014) Efficacy and Safety of Micafungin as Prophylaxis for Invasive Fungal Disease in Neutropenic Patients with Hematologic Malignancies. International Journal of Pharmacology 10:4, pages 231-236.
Crossref
Crossref
S.-X. Xu, J.-L. Shen, X.-F. Tang & B. Feng. (2013) Newer Antifungal Agents for Fungal Infection Prevention During Hematopoietic Cell Transplantation: A Meta-Analysis. Transplantation Proceedings 45:1, pages 407-414.
Crossref
Crossref
A.J. Ullmann, M. Akova, R. Herbrecht, C. Viscoli, M.C. Arendrup, S. Arikan-Akdagli, M. Bassetti, J. Bille, T. Calandra, E. Castagnola, O.A. Cornely, J.P. Donnelly, J. Garbino, A.H. Groll, W.W. Hope, H.E. Jensen, B.J. Kullberg, C. Lass-Flörl, O. Lortholary, W. Meersseman, G. Petrikkos, M.D. Richardson, E. Roilides, P.E. Verweij & M. Cuenca-Estrella. (2012) ESCMID
guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clinical Microbiology and Infection 18, pages 53-67.
Crossref
Crossref
Xiaojun Huang, Huan Chen, Mingzhe Han, Ping Zou, Depei Wu, Yongrong Lai, He Huang, Xiequn Chen, Ting Liu, Huanling Zhu, Jianmin Wang & Jianda Hu. (2012) Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation 18:10, pages 1509-1516.
Crossref
Crossref
Andrew J. Ullmann & Wibke Klaas. (2012) Safety of micafungin in prospective and retrospective clinical trials. Mycoses 55, pages 58-64.
Crossref
Crossref
Maria N. Gamaletsou, Nikolaos V. Sipsas & Dimitrios P. Kontoyiannis. (2012) Micafungin in haematology. Mycoses 55, pages 13-23.
Crossref
Crossref
Akira Onishi, Daisuke Sugiyama, Yoshinori Kogata, Jun Saegusa, Takeshi Sugimoto, Seiji Kawano, Akio Morinobu, Kunihiro Nishimura & Shunichi Kumagai. (2012)
Diagnostic Accuracy of Serum 1,3-β-
d
-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis
. Journal of Clinical Microbiology 50:1, pages 7-15.
Crossref
Crossref
Steven A. Pergam, Debra K. Mattson & Michael Boeckh. 2012. Leukemia and Related Disorders. Leukemia and Related Disorders
309
365
.
Ma?gorzata Mikulska & Claudio Viscoli. (2011) Current Role of Echinocandins in the Management of Invasive Aspergillosis. Current Infectious Disease Reports 13:6, pages 517-527.
Crossref
Crossref
Miguel Salavert & Isidro Jarque. (2011) ¿Es útil el uso de micafungina en la profilaxis de la enfermedad fúngica invasora en el paciente hematológico?. Enfermedades Infecciosas y Microbiología Clínica 29, pages 43-49.
Crossref
Crossref
Yuan Lu, Yi-Qiang Chen, Ya-Ling Guo, Shou-Ming Qin, Cong Wu & Ke Wang. (2011) Diagnosis of Invasive Fungal Disease Using Serum (1→3)-β-D-Glucan: A Bivariate Meta-Analysis. Internal Medicine 50:22, pages 2783-2791.
Crossref
Crossref